PT  - JOURNAL ARTICLE
AU  - Charit Samyak Narayanan
TI  - Modeling the COVID-19 outbreak in the United States
AID  - 10.1101/2020.04.30.20086884
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.30.20086884
4099  - http://medrxiv.org/content/early/2020/05/12/2020.04.30.20086884.short
4100  - http://medrxiv.org/content/early/2020/05/12/2020.04.30.20086884.full
AB  - The COVID-19 contagion has developed at an alarming rate in the US and as of April 24, 2020, tens of thousands of people have already died from the disease. In the event of an outbreak like such, forecasting the extent of the mortality that will occur is crucial to aid the implementation of effective interventions. Mortality depends on two factors: the case fatality rate and the case incidence. We combine a cohort-based model that determines case fatality rates along with a modified logistic model that evaluates the case incidence to determine the number of deaths in all the US states over time; the model is also able to include the impact of interventions. Both models yield exceptional goodness-of-fit. The model predicted a range of death outcomes (79k to 246k) all of which are considerably greater than the figures presented in mainstream media. This model can be used more effectively than current models to estimate the number of deaths during an outbreak, allowing for better planning.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data on COVID-19 are available from: https://github.com/CSSEGISandData/COVID-19 All data on United States state populations are available from: https://www.census.gov/data/datasets/time-series/demo/popest/2010s-state-